KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cardinal Health (CAH) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for Cardinal Health (CAH) over the last 16 years, with Q4 2025 value amounting to $471.0 million.

  • Cardinal Health's Net Income towards Common Stockholders rose 1745.64% to $471.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.7 billion, marking a year-over-year increase of 2764.66%. This contributed to the annual value of $1.6 billion for FY2025, which is 8393.9% up from last year.
  • Cardinal Health's Net Income towards Common Stockholders amounted to $471.0 million in Q4 2025, which was up 1745.64% from $454.0 million recorded in Q3 2025.
  • In the past 5 years, Cardinal Health's Net Income towards Common Stockholders registered a high of $508.0 million during Q1 2025, and its lowest value of -$1.4 billion during Q1 2022.
  • Over the past 5 years, Cardinal Health's median Net Income towards Common Stockholders value was $238.0 million (recorded in 2024), while the average stood at $151.5 million.
  • In the last 5 years, Cardinal Health's Net Income towards Common Stockholders crashed by 129827.59% in 2022 and then surged by 766666.67% in 2024.
  • Over the past 5 years, Cardinal Health's Net Income towards Common Stockholders (Quarter) stood at $49.0 million in 2021, then plummeted by 257.14% to -$77.0 million in 2022, then soared by 579.22% to $369.0 million in 2023, then rose by 8.67% to $401.0 million in 2024, then increased by 17.46% to $471.0 million in 2025.
  • Its Net Income towards Common Stockholders stands at $471.0 million for Q4 2025, versus $454.0 million for Q3 2025 and $243.0 million for Q2 2025.